A triple combination of treatments on moderate COVID-19

Bao ChunMiao; Li BinBin; Zhou YuFeng

doi:10.1515/med-2021-0279

Open Medicine (May 2021)

A triple combination of treatments on moderate COVID-19

Bao ChunMiao,
Li BinBin,
Zhou YuFeng

Affiliations

Bao ChunMiao: Department of Respiratory Medicine, The Affiliated Yangming Hospital of Ningbo University, Yuyao People’s Hospital of Zhejiang Province, Zhejiang, China
Li BinBin: Department of Infection, YongJia County People’s Hospital, Shangtang Road, Wenzhou, 325000, China
Zhou YuFeng: Department of Intensive Care Unit, The Affiliated Yangming Hospital of Ningbo University, Yuyao People’s Hospital of Zhejiang Province, Zhejiang, China

DOI: https://doi.org/10.1515/med-2021-0279
Journal volume & issue: Vol. 16, no. 1
pp. 769 – 772

Abstract

Read online

A triple combination of interferon (IFN) α-2b, lopinavir tablets, and umifenovir was used to treat COVID-19 patients. It is important to explore whether the benefit of this therapy is time dependent.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords